Rapid acceleration of diagnostics (radx) program tech project #7697: sars-COV-2 AG home test
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92021C00010
- Awardee
-
Mologic Inc. UEI UJXLCMKNFXD4
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $16,239,965
Award facts
- Opportunity
-
- Rapid Acceleration of Diagnostics (RADx) Tech: Project 7697 – SARS-COV-2 Ag Home Test Award Notice · Posted Mar 31, 2021
- Contract value 100% obligated
- $16,239,965.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Biomedical Imaging and Bioenginering National Institutes of Health, Department of Health and Human Services
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Bedford, NH 03110, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Definitize Change Order | $0 | |
| Definitize Change Order | $0 | |
| Supplemental Agreement for work within scope | $4,475,450 | |
| Supplemental Agreement for work within scope | $0 | |
| Definitize Change Order | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Definitize Change Order | $0 | |
| Original award | $11,764,515 |
About this award
The U.S. National Institute of Biomedical Imaging and Bioengineering, part of the Department of Health and Human Services, awarded a $16,239,965.00 firm fixed price contract to Mologic Inc., a foreign-owned for-profit organization, for the Rapid Acceleration of Diagnostics (RADx) Program Tech Project #7697: SARS-CoV-2 Antigen Home Test. This contract, which does not have a set-aside designation, aims to deliver the testing products through January 2025 from Mologic's facility in Bedford, New Hampshire. Mologic Inc. has provided SARS-CoV-2 antigen home tests to the National Institutes of Health under this program to accelerate COVID-19 diagnostics, and has also supported the NIH's National Institute of Allergy and Infectious Diseases through custom antibody development and clinical studies on new point-of-care COVID-19 testing devices. This contract work aligns with the NIH's goal of facilitating public health through rapid testing technologies.
Quick answers
Who was awarded contract 75N92021C00010?
75N92021C00010 was awarded to Mologic Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on March 31, 2021.
How much is contract 75N92021C00010 worth?
The government has obligated $16,239,965 on 75N92021C00010.
Which agency awarded contract 75N92021C00010?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92021C00010, with funding from National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health).
Was contract 75N92021C00010 competed?
The extent of competition for 75N92021C00010 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award